The European pharmaceutical excipient market is estimated to grow at a CAGR of 5.3% during the forecast period. The market growth is attributed to the presence of well-established pharmaceutical and biopharmaceutical industries in the region. Significant funding in the biopharmaceutical companies coupled with the presence of major market players such as Meggle AG is another major factor for the significant growth of the market in the region.

The European pharmaceutical excipient market is segmented on the basis of product and formulations. Based on the product, the market is segmented into solubilizers & surfactants/emulsifiers, polyols, carbohydrates, and specialty excipients. Solubilizers & Surfactants/Emulsifiers covered in the report include triglycerides, esters, and others. in addition, polyols include mannitol, sorbitol, and others. Carbohydrates including sucrose, dextrose, starch, and others are estimated to hold a prominent share in the market. Based on formulations, the market is segmented into oral formulations, topical formulations, parenteral formulations, and other formulations. Oral formulations held a remarkable share in the market.

Geographically, the European market report covers the country-level analysis of the UK, Germany, Italy, Spain, France, and the rest of Europe. Germany holds a significant share and contributing considerably to the market growth with a remarkable growth rate. Moreover, the recent COVID-19 outbreak in the region and across the globe has increased the demand for drugs for the prevention and treatment of the virus. This, in turn, has significantly increased the demand for pharmaceutical excipient and hence drives the market growth.

Moreover, the European pharmaceutical excipients market report covers the analysis of various players operating in the market. Some of the players operating in the market include Merck KGaA, DFE Pharma, BASF SE, Roquette Freres SA, Lubrizol Corp., and others. Owing to increasing competition in the market, the players in the market adopting various strategies such as merger and acquisition and partnership and collaboration that tend to fuel market growth in the near future.

For instance, in September 2017, Roquette Freres SA acquired Itacel from Blanver. Itacel was a major manufacturer of pharmaceutical excipients in Latin America (Brazil). By the acquisition, the company aims to increase its market reach of natural-based pharmaceutical excipients solutions.

Research Methodology

The market study of the European pharmaceutical excipients market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research has been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for pharmaceutical excipients manufacturers, suppliers, raw material suppliers, traders, third-party distributors, healthcare industry, pharmaceutical and biopharmaceutical manufacturers, government organizations, regulatory authorities, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products & services offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. European Pharmaceutical Excipients Market Research and Analysis by Product
2. European Pharmaceutical Excipients Market Research and Analysis by Formulations

The Report Covers

• Comprehensive research methodology of the European Pharmaceutical Excipients Market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the European Pharmaceutical Excipients Market.
• Insights about market determinants which are stimulating the European Pharmaceutical Excipients Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.